Navigation Links
ProSource 2.0 Offers Value, Savings for Lab Supplies
Date:9/16/2008

ProSource 2.0 is a customized lab supply ordering system that allows users to create a personalized, online catalog of every lab supply they currently order. ProSource then provides these items in one location with negotiated low prices to ensure savings on every order. ProSource eliminates the need to order from multiple suppliers, allows every lab in your company to order from the same location, all while helping to eliminate errors in ordering, payable and receivables. ProSource is brought to you by The Lab Depot, an online leader in lab supplies.

Dawsonville, GA (PRWEB) September 16, 2008 -- http://www.labdepotinc.com [The Lab Depot __title__ The Lab Depot], a leading online provider of laboratory supplies, announces the release of http://www.labdepotinc.com/about/prosource.php [ProSource 2.0 __title__ ProSource], a customized ordering system that provides value and savings for labs with high quality products at discount prices.

"We are excited to offer ProSource as an alternative for lab professionals tired of paying huge mark-ups to big supply companies," said Don Westall, CEO of The Lab Depot. "With ProSource, we offer the same high quality products our clients are used to at vastly reduced prices," he said.

At no cost, ProSource allows clients to create their own personalized, online catalog complete with the entire inventory of http://www.labdepotinc.com/about/prosource.php [lab supplies __title__ ProSource] they currently order. Each item in their catalog features negotiated low prices to ensure savings on every order.

In addition to pricing, ProSource makes it easier than ever to manage the purchasing process. By combining the lab sup
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
2. Radio wave cooling offers new twist on laser cooling
3. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
4. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
5. Microtest Offers Free White Paper: Virus Testing for Biological Products: Partnering With a Contract Lab
6. HollisterStier Offers Comfort With New ComforTen(TM) Multiple Skin Testing Device
7. Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market
8. Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community
9. New Online Help Desk Offers Safe Lifting Assistance to Healthcare Facilities
10. Woodbridge Offers the Broadest Range of BioFoam(TM) Green Polyurethane Automotive Interior Applications
11. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4